Revenue: The sum of all revenue fields included for a company's operating activities.
Gyre Therapeutics, Inc. (GYRE) had Revenue of $30.56M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$30.56M |
$3.61M |
|
$1.63M |
|
$28.94M |
|
$23.64M |
|
$6.93M |
|
$0.70M |
|
$7.63M |
|
$7.63M |
|
$5.94M |
|
$5.94M |
|
$5.94M |
|
$5.94M |
|
$6.93M |
|
$7.58M |
|
90.85M |
|
103.97M |
|
$0.04 |
|
$0.03 |
|
| Balance Sheet Financials | |
$98.58M |
|
$23.61M |
|
$60.81M |
|
$159.38M |
|
$15.91M |
|
-- |
|
$6.06M |
|
$21.97M |
|
$137.41M |
|
$132.57M |
|
$137.41M |
|
90.89M |
|
| Cash Flow Statement Financials | |
$6.63M |
|
$-2.32M |
|
$24.06M |
|
$11.81M |
|
$40.40M |
|
$28.59M |
|
$2.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.67% |
|
22.66% |
|
22.66% |
|
-- |
|
24.96% |
|
11.81% |
|
$5.61M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.18 |
|
1.17 |
|
76.88 |
|
4.32% |
|
4.48% |
|
3.72% |
|
4.32% |
|
$1.51 |
|
$0.05 |
|
$0.06 |
|